The PAT initiative aims, among other things, to develop processes that ensure consistent quality of the end product, while improving efficiency and addressing regulatory concerns.
The PAT initiative aims, among other things, to develop processes that ensure consistent quality of the end product, while improving efficiency and addressing regulatory concerns.
Manufacturers are continually experimenting with new drug delivery devices and innovative packaging configurations to increase efficiency, safety and ease-of-use.
Through its reform of pharmaceutical GMPs and the Critical Path program, the FDA have attempted to address and reverse what we all know to be the root issues of US pharma.
Not-so-simple: the dilemma of modern packaging. By Bryan D Stolle